1. Mu opioid receptors inhibit GABA release from parvalbumin interneuron terminals onto CA1 pyramidal cells
- Author
-
Pei Chen, Kun Yang, Mingwei Zhao, Qian Chen, Caifeng Shao, and Wei-Ning Zhang
- Subjects
Male ,0301 basic medicine ,Interneuron ,Receptors, Opioid, mu ,Biophysics ,Hippocampus ,Mice, Transgenic ,Optogenetics ,Biochemistry ,Whole-Cell Recordings ,03 medical and health sciences ,0302 clinical medicine ,Interneurons ,mental disorders ,polycyclic compounds ,medicine ,Animals ,CA1 Region, Hippocampal ,Molecular Biology ,gamma-Aminobutyric Acid ,biology ,Chemistry ,Pyramidal Cells ,Cell Biology ,Enkephalin, Ala(2)-MePhe(4)-Gly(5) ,Parvalbumins ,030104 developmental biology ,medicine.anatomical_structure ,nervous system ,030220 oncology & carcinogenesis ,biology.protein ,GABAergic ,Female ,μ-opioid receptor ,human activities ,Neuroscience ,Parvalbumin ,Homeostasis - Abstract
Selectively activating (by optogenetics) parvalbumin-expressing (PV) interneurons induces GABA release onto CA1 pyramidal cells. Here we report that this release was attenuated by presynaptic mu opioid receptors (MORs) activation. On the other hand, conventional electric shock, presumably activating non-selectively presynaptic GABAergic terminals, also induced GABA release; however, this release showed relatively limited depression by MORs activation. The data suggest that MORs specifically inhibit GABA release from PV terminals and therefore, further support the idea that MORs contribute to homeostasis in CA1 neuro-circuit.
- Published
- 2020
- Full Text
- View/download PDF